Showing results (141-150 of 428) with videos related to
Sort By:
Pageof 43
Neurocritical Care|June 8, 2006
Recombinant activated factor VII for acute intracerebral hemorrhage: US phase IIA trialStephan A Mayer, Nikolai C Brun, Joseph Broderick, et al.Neurosurgery|February 28, 2008
The impact of microsurgical fenestration of the lamina terminalis on shunt-dependent hydrocephalus and vasospasm after aneurysmal subarachnoid hemorrhageRicardo J Komotar, David K Hahn, Grace H Kim, et al.Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|May 18, 2010
Relationship between brain interstitial fluid tumor necrosis factor-α and cerebral vasospasm after aneurysmal subarachnoid hemorrhageKhalid A Hanafy, R Morgan Stuart, Alexander G Khandji, et al.Journal of the American Heart Association|August 27, 2024
Acute Myocardial Injury in Spontaneous Intracerebral Hemorrhage: A Secondary Observational Analysis of the FAST TrialMichela Rosso, Helena Stengl, Jan F Scheitz, et al.BMC Neurology|December 20, 2022
The REACT study: design of a randomized phase 3 trial to assess the efficacy and safety of clazosentan for preventing deterioration due to delayed cerebral ischemia after aneurysmal subarachnoid hemorrhageNicolas Bruder, Randall Higashida, Hugues Santin-Janin, et al.The Journal of Neuroscience Nursing : Journal of the American Association of Neuroscience Nurses|December 16, 2014
Risk factors for catheter-associated urinary tract infections in critically ill patients with subarachnoid hemorrhageThomas Hagerty, Louise Kertesz, J Michael Schmidt, et al.Journal of Critical Care|February 8, 2018
Addressing spirituality during critical illness: A review of current literatureBarbara S Gordon, Maggie Keogh, Zachary Davidson, et al.Neurosurgery|August 3, 2006
Critical postcraniotomy cerebrospinal fluid hypovolemia: risk factors and outcome analysisRicardo J Komotar, Evan R Ransom, J Mocco, et al.Neurosurgery|October 14, 2006
Dynamics of intraventricular hemorrhage in patients with spontaneous intracerebral hemorrhage: risk factors, clinical impact, and effect of hemostatic therapy with recombinant activated factor VIIThorsten Steiner, Michael N Diringer, Dietmar Schneider, et al.JAMA|February 19, 2004
Initial misdiagnosis and outcome after subarachnoid hemorrhageRobert G Kowalski, Jan Claassen, Kurt T Kreiter, et al.Pageof 43